Contact this trialFirst, we need to learn more about you.
Virus Therapy
Yellow Fever Vaccine Immune Response Tracking for Yellow Fever
Recruiting4 awardsPhase 4
Decatur, Georgia
This trial will use D20 to track YFV specific CD8+ T cells in human vaccinees who are positive for a specific HLA type, HLA A202. D20 will help us understand how long these cells live and how often they divide to create new cells. This will give us a better understanding of the immune response to live viral infections.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.